Robin Wright
Director · Barinthus Biotherapeutics plc.
Individual
- 2026
- Sep 9, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Robin Wright's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BERKSHIRE HATHAWAY INC - $488.34M in DVA purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $399.66M in SYRE purchases and sales in the last 12 months
- August J. Troendle - $358.45M in MEDP purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Paul R. Vigano - $268.34M in AVAH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robin Wright?
Robin Wright is a corporate insider, tracked as Director of Barinthus Biotherapeutics plc. (BRNS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robin Wright submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
